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Abstract  The attainment of a specific mature body size is one of the most fundamental
differences among species of mammals. Moreover, body size seems to be the central factor
underlying differences in traits such as growth rate, energy metabolism and body composition.
An important proportion of this variability is of genetic origin. The goal of the genetic analysis
of animal growth is to understand its “genetic architecture”, that is the number and position of
loci affecting the trait, the magnitude of their effects, allele frequencies and types of gene action.
In this review, the different strategies developed to identify and characterize genes involved in
the regulation of growth in the mouse are described, with emphasis on the methods developed
to map loci contributing to the regulation of quantitative traits (QTLs).
genetics / growth / mouse / mapping / QTLs
1. INTRODUCTION
The mature body size of an animal is determined by the number and size
of its cells, and the amount of extracellular matrix and fluid [23], with cell
number making a major contribution [2]. A crucial feature of the development
of mammals is that at a given point, an animal stops growing, reaching at that
point a maximum cell mass. It is accepted that the genetic makeup of the
individual plays a predominant role in the determination of that endpoint, but
the underlying genetic mechanisms are not well understood [23]. Therefore,
one of the primary objectives of the genetic analysis of animal growth is to
understand its “genetic architecture”, that is the number and position of loci
affecting the trait, the magnitude of their effects, allele frequencies and types
of gene action [12,128].
The mouse has been extensively used as a model to study the genetics of
growth in mammals. Information compiled in the Mouse Genome Database
(MGD) [87] gives an idea of the complexity of the genetic regulation of growth
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in the mouse. As of March 2001, 650 genes in MGD were described as having
some phenotypic effect on growth. In this review, the different strategies
developed to identify and characterize genes involved in the regulation of
growth in the mouse will be described, with emphasis on the methods developed
to map loci associated to the regulation of quantitative traits (QTLs).
1.1. Selection experiments
Research on the genetics of animal growth was initially conducted to test
the theoretical concepts of quantitative genetics. A hallmark of this work in
animal genetics was the development of long-term selection experiments [40] to
confirm the efficacy of selection to permanently change the mean of continuous
traits in the absence of major mutations, and to verify if there was a limit
to the response to selection. The results of these studies showed that most
of the growth-related traits had medium-to-high heritability, indicating that
additive genetic effects were an important component of the genetic architecture
underlying differences in growth. Estimates of realized heritability for body
weight and growth rate are in the range between 0.18 and 0.35 [37,83], whereas
the estimates corresponding to traits associated with body composition are
between 0.18 and 0.66 [38].
Selection experiments also revealed the existence of strong genetic correla-
tions among traits that were indicative of the complexity of growth regulation
at both physiological and genetic levels. For example, Hill and Bishop [53]
reviewed the results of different selection experiments and concluded that
in most cases, selection for growth rate in the mouse increased the level of
food intake, improved feed conversion efficiency and enhanced fat deposition,
with little change in maintenance requirements and relative growth rate. In
contrast, selection for appetite increased both maintenance requirements and
growth rate, with little change in conversion efficiency, whereas selection for
lean mass increased body weight, keeping body composition and maintenance
requirements constant.
Although selection experiments produced a large amount of information
pertaining to the genetic regulation of growth, the nature of these experiments,
based on mass selection schemes, precluded the identification of individual
genes. However, the theoretical model that explained the genetic origin of
continuous variation and the response to selection, allowed the estimation of
the number of loci regulating a given trait [41]. According to that model, the
number of loci involved in the regulation of a quantitative trait is a function of
the original additive variance of the base population and the difference of means
between the two divergent lines at the selection limit. Given a certain additive
variance in the base population, the more loci affecting the trait, the smaller their
individual effect and the larger the maximum difference between line means. In
a divergent selection experiment for 6-wk weight in mice, the estimated number
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Table I. Summary of single-gene mutations affecting growth in the mouse.
Mutation Symbol Chrom. Gene responsible Reference
Snell dw 16 Pituitary specific transcription
factor 1 (Pit1) [13]
Ames df 11 Paired like homeodomain
factor 1 (Prop1) [109]
Little lit 6 GH-releasing
hormone receptor (Ghrhr) [50]
pygmy pg 10 High mobility group
protein I, isoform C (Hmgic) [130]
miniature mn 15 Unknown [3]
diminutive dm 2 Unknown [110]
high growth hg 10 Socs2/Cish2 [6,56]
of loci affecting growth was 32 [41]. These estimations, however, were based
on the assumption that all the involved loci have effects of equal magnitude,
and did not take into account the potential increase in additive variance due
to new neutral mutations [65]. However, the recent availability of molecular
markers and linkage maps has made it possible to perform genome scans to
identify QTLs and test the original theoretical hypothesis on the number and
magnitude of effects of loci regulating growth. These genome scans involve the
systematic screening of markers distributed throughout the genome to identify
loci that have significant associations with quantitative traits [114].
1.2. Single-gene mutations
An important tool for genetic analysis of growth traits has been the char-
acterization of single-gene mutations producing major phenotypic changes in
mice. A summary of known single-gene mutations having a major effect on
body size is presented in Table I [81,87]. Three of these mutations, Snell
(dw), Ames (df ) and little (lit), affect the Growth Hormone (GH) regulatory
pathway at different levels. The pygmy (pg) mutation is due to a disruption
of the Hmgic gene on chromosome 10 [130]. The Hmgic gene codes for
a High mobility group (HMG) protein. These are very abundant non-histone
chromosomal proteins that participate in structural changes to chromatin during
transcription [11]. Two other less-known mutations that cause dwarfism in the
mouse are miniature (mn) and diminutive (dm). These mutations have been
mapped to chromosomes 15 and 2, respectively [87], but the genes responsible
for these two mutations are yet to be identified.
In contrast to a fairly high number of known mutations producing a reduction
in growth, mouse models of enhanced growth are rare, with the exception of
those producing obesity (reviewed by Pomp [100]). The high growth (hg)
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locus, however, is a unique spontaneous, autosomal mutation that enhances
weight gain and body size by 30–50% in the mouse [6,85]. Despite the drastic
change in growth rate, hg/hg mice are proportionate in the size of tissues and
organs [42,111] and are not obese [25]. Genetic and physical mapping have
determined that a deletion in chromosome 10 is responsible for this particular
phenotype [55]. Recently, the high growth phenotype has been identified as
resulting from a lack of expression of the suppressor of cytokine signaling 2
(Socs2 or Cish2) which is partially deleted [56].
1.3. Transgenics and knockouts
Targeted gene deletions (gene knockouts) and transgenics are two methods
of characterizing the function of a gene which follow opposite strategies. In
the case of transgenic mice, extra copies of a gene are integrated at random
in the genome of a recipient animal. A dramatic example of the application
of this technology to the study of growth genes was presented in the series of
experiments involving transgenic mice for the Growth Hormone (GH) gene,
described by Palmiter et al. [97,98], and several other groups [19,62,125].
The gene-knockout methodology involves the manipulation of the genome
to create loss-of-function phenotypes. In this method, functional alleles are
replaced by null alleles in Embryonic Stem (ES) cells that are later integrated
into mouse blastocysts [96]. Targeted deletion of two cyclin-dependent kinase
(CDK) inhibitors leads to increased body size and organomegalia. Mice
homozygous for a deletion on the p18INK4c gene were 30% heavier than control
mice at 3 months of age [48]. The heart, kidney and liver of those mice
were proportionate, whereas the spleen and thymus were disproportionately
enlarged. Furthermore, mice lacking p18 developed pituitary adenomas. A
very similar phenotype is characteristic of mice lacking the p27Kip1 gene [43,
69,93]. Adult mice with two copies of the disrupted gene were 30% larger than
control mice. In addition to their more rapid growth, females had impaired
maturation of ovarian follicles.
Targeted disruption experiments have revealed a novel category of growth
inhibitors. Cloning of the myostatin gene, a member of the Transforming
Growth Factor superfamily β (TGF-β) proved the existence of tissue-specific
molecules controlling organ size. Mice lacking the myostatin gene have
muscles that are up to three times larger than normal [84]. Interestingly,
spontaneous mutations on the same gene have been detected in the double-
muscled breeds of beef cattle [61,76]. Myostatin is an extracellular factor
expressed almost exclusively in skeletal muscle that affects both cell number
and size [84]. The mechanism for the inhibition of growth by myostatin has
not been established.
Two elegant targeted disruption experiments were conducted to assess the
importance of systemic IGF-I produced by the liver in the regulation of
Mapping of growth QTLs in the mouse 109
growth [108,126]. The Igf-I gene was disrupted in hepatic cells using the
Cre-loxP recombination system. Targeted expression of the Cre recombinase
to the liver was driven by the albumin promoter. The Igf-I gene in non-hepatic
tissues was left intact. Surprisingly, suppression of Igf-I expression in the
liver had no noticeable effects on growth. At 6 weeks of age, there were no
differences in body and femur length, and liver, kidney and heart weights.
Only the spleen was smaller in knockout mice. These results emphasize the
importance of paracrine and autocrine IGF-I on growth promotion.
A comprehensive list of gene knockouts and transgenics that includes models
for the study of growth regulation has been compiled by The Jackson Laboratory
in the Transgenic/Targeted Mutation Database1. However, knowledge about
the phenotype of knockout mice is not enough to categorize a gene as a growth
regulator, because impaired growth could be produced as a side effect of a
gene that does not normally control growth. Efstratiadis [36] proposed some
conditions to be met by a gene in order to consider it involved in growth con-
trol: overexpression of a growth-promoting gene should result in overgrowth,
whereas gene suppression should produce growth retardation. Opposite res-
ults should be obtained with growth-inhibiting genes; however, in this case
overgrowth produced by loss of function would constitute sufficient evidence.
2. GENOME-WIDE SCANS TO IDENTIFY QUANTITATIVE
TRAIT LOCI (QTLs)
The methodologies involving transgenics and targeted gene disruptions
require previous knowledge about a gene associated with the phenotype under
study. On the contrary, the experimental approach known as positional cloning
was developed in order to identify anonymous genes underlying complex traits,
without previous knowledge about their functions and based solely on their
position in the genome [21,114]. Although the association between markers
and quantitative traits has been known for a long time [107], it was the devel-
opment of molecular techniques that allowed the large scale characterization
of polymorphic loci at the DNA level which has permitted the search for loci
underlying quantitative variation over the last decade. Initially, Restriction
Fragment Length Polymorphisms (RFLP) analyzed by Southern Hybridization
were used [5], which in time were replaced by less expensive, PCR based
markers such as Simple-Sequence Length Polymorphisms (SSLP) [32]. A new
generation of markers, namely the Single Nucleotide Polymorphisms (SNPs),
will probably replace the SSLP for linkage analysis, based on promising fea-
tures such as their abundance in the genome and the possibility of automated
typing [8,9,79].
1 http://tbase.jax.org/
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The available mouse inbred lines are a valuable resource to create mapping
populations because the identity and phase of the segregating alleles, of which
there are usually only two, are known [45]. However, the methodology has been
extended to outbred populations [113] and populations created from selection
experiments [54,64].
2.1. Experimental designs used in QTL mapping
Usually, one of two alternatives is chosen to create a resource population
suitable for QTL mapping. Two inbred mouse lines, usually contrasting for the
phenotype of interest, are crossed to produce the F1 generation. F1 mice are
crossed to either one or both of the parental lines to create a backcross, or they
are intercrossed to create an F2 population.
Lander and Botstein [74] discussed some of the aspects related to experi-
mental designs in QTL mapping experiments, and concluded that the power to
detect QTLs depended on the magnitude of the phenotypic difference between
strains, number of segregating QTLs, number of markers and population size.
The larger the difference between strains and the fewer the QTLs, the fewer
animals needed. According to these authors, if other factors are equal, fewer
animals are needed from an F2 cross compared to a backcross, because the F2
cross provides twice as much meiosis. Another advantage of the F2 over the
backcross is that in F2 crosses all the segregating alleles can be found in all
possible phases among the offspring.
Darvasi [28] derived expressions to calculate the detection power of the most
common experimental designs. According to this author, the F2 cross would
only reduce the number of animals needed to estimate additive effects by
30% compared to the backcross, because the backcross design requires lower
significance thresholds [73,75] and there is also a reduction of the genetic
variance compared to the F2 cross. Backcrosses are more efficient than F2
crosses for the estimation of dominance effects; in equal conditions the same
power could be achieved with up to 50% reduction in population size. Dupuis
and Siegmund [35] conducted simulation studies in order to compare different
experimental designs. According to their results, an F2 cross is especially more
efficient than a backcross when the QTLs have a small additive effect, and when
there is dominance with effects of opposite sign to the additive effects. They
also concluded that for either design, there was little gain in power when mark-
ers were spaced less than 10 cM apart. Apart from all these theoretical consider-
ations, there are also practical issues that influence the choice of a scheme, such
as the availability of mice for reproduction and the fertility of F1 individuals.
A different approach used to establish linkage to a QTL is to follow changes
in allele frequencies between lines produced by long-term divergent selec-
tion [49]. Kim and Stephan [67] evaluated the power of the method compared
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to mapping in an F2 cross. For example, a QTL with a given effect that would
require an F2 cross of 1 050 mice for detection could also be identified after
selecting for 14 generations among a population of 90 individuals. However,
the power of the method is very sensitive to changes in the number of markers,
effective population size and recombination rate between a QTL and a marker.
Keightley et al. [64] have successfully applied this method to map QTLs
affecting 6-wk body weight.
The strategy known as selective genotyping has been proposed to save time
and resources in genome scans. In this method only a fraction of the population
corresponding to the animals with extreme phenotypes is genotyped [26,29].
Animals from the extremes of the distribution of phenotypes provide more
linkage information [74]. Therefore, up to 80% of the maximum statistical
power can be maintained even if only 50% of the population from the extremes
of the distribution is typed [29]. Although selective genotyping allows to detect
linkage disequilibrium between a marker and a QTL, estimation of gene effects
is not possible because they would be severely overestimated [29]. Therefore,
selective genotyping is usually applied in a two-stage procedure. In the first
stage, only extreme animals are typed to find evidence of linkage to QTLs in
specific chromosomal regions, and in the second stage the entire population is
typed for markers only on the most promising chromosomal regions [90,124].
A variant of the selective genotyping strategy involves the pooling of DNA
samples in order to drastically reduce the genotyping work. The existence of
linkage between a QTL and a marker is established by assessing if differential
allelic representation exists in the pooled DNA samples from extreme indi-
viduals, which can be estimated by quantification of the corresponding PCR
product. Darvasi and Soller [30] discussed theoretical aspects of selective DNA
pooling and derived expressions to calculate the proportion of the population
to be genotyped in order to maximize the power of the test. The minimization
of technical errors in allele quantification is of particular importance to keep
the power of selective genotyping at its maximum. Wang and Paterson [121]
discussed other factors affecting the efficiency of the method, such as type
of gene action, population type and the existence of segregation distortion.
Selective DNA pooling has been successfully used by Taylor and Phillips [116]
to map obesity QTLs in the mouse. In this experiment, the contribution from
individual animals to the DNA pools was proportional to the difference between
their phenotypic value and the population mean, in order to maximize the
difference in allelic representation.
2.2. Statistical analysis
Manly and Olson [82] have recently reviewed the methods and current
software available for QTL mapping. The principles underlying QTL mapping
are straightforward. In the simplest case, classification of individuals in the
112 P.M. Corva, J.F. Medrano
population based on their genotype for a given marker makes it possible to
compare the phenotypic means of the different genotypic classes [114]. If
after the application of a statistical test a significant difference is detected
among these classes, it could be deduced that there is a locus affecting the
studied trait linked to the marker. There is a limitation to this approach.
When single markers are used in the analysis, the magnitude of the QTL effect
and its distance to the marker are confounded, e.g. the QTL effects will be
underestimated by a factor equal to (1− 2× c), where c is the recombination
rate between the locus and the marker [41]. To overcome this limitation, new
mapping strategies have been developed. In the methods based on interval
mapping, a pair of markers is analyzed simultaneously and statistical tests
determine the most likely position of a QTL within that interval [114]. To
perform interval mapping, a fairly dense linkage map is needed in advance [74].
Current methods to map QTLs are based on one of two statistical procedures:
maximum likelihood (ML) and regression (least squares) analysis [33]. Least-
square methods have the advantage of being computationally simpler and easy
to implement with any statistical software package [52]; therefore, they have
become very popular. They are also robust enough in case of departures from
the assumptions of normality. Nonparametric tests have been developed that
do not depend on the assumption of normal distribution [72].
Some variants have been introduced into the interval mapping methodology
in order to improve the accuracy of QTL detection. The method called com-
posite interval mapping includes markers outside the interval being analyzed
in the models, to account for background genetic effects [57,127]. There
are programs available that automatically select these cofactors, usually using
regression [82].
A statistical problem concerning the levels of significance arises in genome-
wide scans for QTLs, because a large number of tests are performed which
are not statistically independent [73]. Therefore, using an “unprotected”
significance level will lead to the detection of many false positives. Lander and
Kruglyak [73] proposed a series of standard thresholds to be used in complex
trait mapping with the most common experimental designs. Based on genome
size, crossing over rate and pointwise significance levels, the recommended
thresholds to declare significant linkage (genome-wide p < 0.05) in mouse
intercrosses were LOD = 4.3 and p = 5.2× 10−5. In the case of “suggestive”
linkage, the respective values were reduced to LOD= 2.8 and p = 1.6×10−3.
Churchill and Doerge [18] have proposed a method to establish empirical
threshold values in genome-wide scans that has become widely accepted by
researchers in this area. The method is based on the theory of permutations.
Phenotypic values are reassigned at random among individuals while keeping
their genotypic information, and the linkage analysis to detect QTLs is per-
formed with the shuffled data set. This process is repeated many times (the
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authors suggested a minimum of 1000 runs), in order to create a distribution of
test statistics in the absence of linked QTLs. The 95th percentile value from
that distribution would correspond to a significance threshold of p < 0.05.
Results from QTL mapping experiments should be evaluated with caution.
Due to limitations of the experimental design, there is a statistical bias affecting
the number and magnitude of effects of reported QTLs [63]. With the current
methods for QTL searching, only QTLs with the strongest effects are detec-
ted [114]. This bias is inversely related to the stringency of the significance level
and it is stronger for dominance effects than for additive effects [63]. Although
these limitations of the methodology preclude a faithful characterization of the
genetic architecture of a quantitative trait, they still enable us to utilize the
information on the position of QTLs. As Kearsey and Farquhar [63] stated,
marker-assisted selection and introgression schemes do not require a very
accurate estimation of the location of a QTL, and for such purposes researchers
would probably be more interested in those QTLs with the strongest effect on
the phenotype.
More sophisticated statistical methods are being developed to improve the
power of detection in QTL mapping experiments, such as multiple trait ana-
lysis [58,71] and multiple interval mapping [128]. Although these methods
have not been extensively used to date, they seem to be promising alternatives
to the more conventional mapping strategies, and it is likely that they will be
adopted by researchers in the field.
2.3. Experimental QTL studies in mice
Scientific literature is abundant in results from experiments that have per-
formed genome-wide scans for growth QTLs. These results are summarized
in Table II. Results of obesity studies have been reviewed elsewhere [14,100]
and will not be included here.
The experiment conducted by Cheverud et al. [16] was one of the first to
present results on genome-wide scans for QTLs affecting growth rate and body
weight in a fairly large population (535 LG/J × SM/J, F2 mice). Thirty-one
significant loci were identified on 17 chromosomes (QTLs in Tab. II include
those that are reported in the MGD database). A very important contribution of
this experiment was the identification of independent loci controlling growth at
different ages. The experiment was later repeated with 510 F2 mice [120]
in order to confirm the results. The second analysis detected QTLs on
15 chromosomes. Not all the QTLs identified in the first experiment were
replicated in the second experiment. Replication was low for QTLs with
marginal LOD scores and/or on chromosomes with poor marker coverage.
Data from both populations were integrated and the analysis was repeated to
confirm the existence of QTLs, making this experiment one of the largest that
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has been reported in the literature in terms of population size and number
of growth QTLs detected. In the integrated analysis 20 QTLs were found
on 17 chromosomes (data shown in Tab. II). Twelve QTLs affected early
growth (1–3 wk) whereas 11 QTLs affected late growth (6–10 wk), with 8
common QTLs between both groups. Moreover, four QTLs had sex-specific
effects.
An alternative method to the more common mapping approach to segregating
crosses was used by Keightley et al. [64] to identify growth QTLs. Two
divergent lines were created by recurrent selection for 6-wk body weight
starting from a C57BL/6J (C57) × DBA/2J F2 cross. A total of 93 mice
from the low line and 34 mice from the high line were genotyped. Significant
differences in allele frequency of typed markers between the low and high lines
were considered indicative of linkage to growth QTLs. Following this strategy,
11 significant markers were detected on 10 chromosomes.
Morris et al. [91] conducted a QTL scan on a C57 × DBA/2J F2 cross
with 927 mice, in an attempt to replicate the results obtained by Keightley et
al. [64]. The studied traits were live weight at 3 and 6 weeks of age, and tail
length and body weight at 10 weeks of age. Mice were initially genotyped
for the same markers that were significant in the previous experiment [64],
and QTLs for 6-wk and 10-wk weight were confirmed on chromosomes 1,
4, 6, 9 and 11. These QTLs accounted for a small proportion of the genetic
variance in the population; therefore, more markers were typed in the F2 cross.
Selective genotyping was performed on 173 mice (19% of the population)
selected for 10-wk body weight and carcass fat percentage. The entire F2 cross
was genotyped for the most significant markers. QTLs regulating the three
measured body weights were identified on chromosome 1. Loci associated with
3-wk weight were identified on chromosomes 4, 9 and 11, respectively. Loci
associated with 6-wk weight were mapped to chromosomes 6 and 9, respect-
ively. Significant loci for 10-wk weight were identified on chromosomes 6
and 15. This experiment was in agreement with previous experiments [16,120]
on the existence of specific QTLs regulating growth at different ages. Also, a
QTL with very significant effects on tail length was mapped to chromosome 1.
Brockmann et al. [7] mapped growth QTLs in an F2 cross between a line
selected for high 6-wk weight (DU6) and a control line (DUK). A total of
715 mice from 4 families were genotyped. Recorded traits were 6-wk weight
and liver, spleen and kidney weights. Nine significant QTLs affecting one or
more traits were reported.
Two experiments focused on the search for growth QTLs on the X chromo-
some. Dragani et al. [34] screened two different populations, (C3H/He×Mus
spretus) × C57 (HSB) and (A/J × Mus spretus) × C57 (ASB). Two QTLs
affecting 40-wk weight were detected in both populations, and a third QTL
was detected only in the ASB cross.
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The differential response in growth rate between males and females from
reciprocal crosses between two selected lines, led Rance et al. [103] to hypo-
thesize that an X-linked QTL was involved. The selected lines (P lines) had
genetic material from inbred lines JU and CBA and outbred line CFLP. To map
the putative QTL an F2 cross between the high and low lines with 340 mice
was used. Evidence was produced of a single QTL affecting body weight at 3,
6 and 10 weeks of age. This QTL and the QTL Bw1 of Dragani et al. [34] map
to the same region of chromosome X.
Two papers reported results obtained with crosses between C57 and
Quackenbush-Swiss (QS) lines. A C57 × C57-QS backcross of 311 mice was
typed for markers around the Gh and Igf-I genes [20]. Significant association
was found between body weight and markers on chromosome 10, but not
chromosome 11.
Kirkpatrick et al. [68] evaluated a C57 × IQ5 (QS derived) cross. A total
of 200 F2 and 297 C57 × (C57 × IQ5) mice were used. Initial analysis of the
F2 cross and further analysis of the backcross revealed significant linkage to
QTLs regulating 6-wk body weight, 10-wk body weight and adult body weight
on chromosomes 4 and 11.
Other experiments have focused on the search for QTLs related to obesity
traits, in which body weight was recorded. A problem arises when body weight
is measured close to maturity, because body weight and body fat percentage
are correlated. Therefore, the effect of genes influencing linear growth and
obesity are confounded. Warden et al. [123] reported a QTL for adult body
weight on chromosome 7 in a Spretus × C57 backcross (designated BSB) of
412 mice. Using 252 mice from the same cross, Lembertas et al. [77] identified
a QTL for body length on chromosome X that had no significant effect on body
composition. This QTL probably maps to a similar location to the QTL found
by Rance et al. [103].
Pomp et al. [101] mapped QTL for growth and body composition in a
M16i × (M16i × CAST/Ei) backcross. M16i is an inbred line derived from
a line selected for high 3–6-wk gain. Twenty mice (5%) from each extreme
of the distribution of 12-wk body weights were genotyped, and markers show-
ing significant departures from expected allele frequencies were typed in the
entire population (402 mice). Five significant QTLs were identified on five
chromosomes.
Mehrabian et al. [86] conducted a genome-wide scan for obesity QTLs in a
CAST/Ei × C57 F2 cross of 200 mice. QTLs for adult (6 mo.) body weight
were identified on chromosomes 2 and 15. The QTL on chromosome 15 also
affected body length and was unrelated to obesity traits. The presence of a QTL
for adult body weight mapping to the same region of chromosome 2 identified
by Mehrabian et al. [86] was detected by Lembertas et al. [78] in 84 mice of a
NZB/BINJ × SM/J F2 cross.
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Suto et al. [112] looked for modifiers of the effects of the agouti yellow (Ay)
allele on adult body weight, in 93 a/a and 99 Ay/a mice from a C57 × KK-Ay
F2 cross. KK-Ay is an inbred line that develops non-insulin-dependent diabetes
and severe obesity. A significant locus for 6 mo. body weight was identified
on chromosome 4, in both genotypic classes. Another locus on chromosome 6
was detected as significant in the Ay/a group only, which suggests that there
was an interaction with the Ay allele probably affecting body weight through
the degree of fatness.
Moody et al. [90] screened an F2 cross between C57 and a line (MH) selected
for high energy expenditure [94], in order to identify loci associated with the
regulation of energy balance and related traits. The C57 line was chosen
because it was the line showing the largest differences in energy expenditure
when compared to the selected line in a previous experiment [89]. Loci
associated with body weight at 3, 6 and 10 wks of age were identified on
chromosomes 1 and 17, 1 and 11 and 1, 3 and 11, respectively.
Considering that there are many QTLs involved, directly or indirectly, in
determining body size, it is not unexpected to find an overlap in the location
of many growth QTLs when different mapping experiments are compared.
Therefore, it is valid to speculate about the identity of these QTLs, and pose
the question as to whether they correspond to the same genes. Identified QTLs
are usually designated by a provisional name that refers to the cross, the trait,
and/or the chromosomal location. However, no formal nomenclature rules
have yet been proposed for QTLs. Therefore, it is difficult to establish the
correspondence between QTLs from different experiments without a detailed
analysis of mapping information.
Recently, Keightley and Knott [66] developed a permutation test to evaluate
the correspondence among growth QTLs mapped in three different experi-
ments [7,16,91]. Surprisingly, no evidence of correspondence between any pair
of experiments was found. The authors concluded that a significant correlation
between different experiments is unlikely unless there are few QTLs affecting
a trait and the populations are related.
The lack of QTL concordance among crosses may also be due to the defin-
ition of the phenotypes that have been measured. Growth has been examined
as weight at a given age or weight gain in fixed age increments, when perhaps
it would be more appropriate to standardize the data, taking into account
differences in mature body size. Measurements at the same age are not strictly
comparable between lines that differ in mature body size and can be considered
as different phenotypes.
2.4. Epistasis in QTL experiments
Genes are part of complex networks that regulate all the physiological pro-
cesses that take place in living organisms [80]. Because genes are integrated
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Table II. Summary of reported QTLs associated with weight gain and body size
traits in the mouse. Sources: individual publications, the Human Obesity Gene Map
(http://www.obesity.chair.ulaval.ca/Genes.html) and the Mouse Genome Database
(http://www.informatics.jax.org/searches/marker_form.shtml).
(continued on the next pages)
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into regulatory networks, it is sometimes difficult to assign a function to a
gene. The apparent lack of a phenotype, already mentioned as a limitation of
some gene knockout models, is another example of the complexity of these
networks. In a genome-wide scan for QTLs, only those loci that have a
significant effect independently of the genetic background will be detected.
However, other loci have significant effects on the phenotype only in very
specific allelic combinations with other genes. For example, the BSB cross
(C57BL/6J × Mus spretus F1× C57BL/6J) has a wide range of body fat
contents, from extreme leanness to massive obesity, that is not seen either in
the parental lines or the F1 [122]. There are also examples of QTLs that are
detected as significant when pairs of loci are mapped simultaneously, but not
when a single-QTL scan is conducted, as has been demonstrated in cases of
susceptibility to lung cancer [44] and colon cancer [119] in mice. In the latter
experiment, the influence of interactions among loci on cancer susceptibility
was inferred because a couple of Recombinant Congenic Strains (RCS) were
susceptible, while the parental inbred lines, the F1 and most of the other RCS
were resistant. Another possible interaction between QTLs is a drastic change
in the magnitude and type of genetic effects of one QTL, depending on the
genotype of a second QTL, as demonstrated by Frankel et al. [47] for the
frequency of epileptic seizures in mice.
To take into account this level of complexity, epistasis has been included
in theoretical models of the genetic regulation of quantitative traits. Epistasis
was originally defined as the influence of a gene on the phenotypic expression
of a different non-allelic gene; this definition was later extended to any kind
of gene interaction [46]. Cheverud and Routman [15] made the distinction
between a physiological and a statistical definition of epistasis, that basically
correspond to the aforementioned definitions of epistasis in a narrow and broad
sense, respectively. The terms “interaction deviation” and “synergism” [46]
have also been applied to define non-additive associations among loci.
Although this is currently a very active field of investigation, statistical
methods to map QTLs which include the effects of epistasis are still lim-
ited. Genetic regulatory networks can include hundreds or even thousands of
genes [80]. However, most experiments have only analyzed two-loci interac-
tions between markers [106]. In other cases, interacting QTLs are searched after
one significant locus has already been detected [82]. Although not completely
satisfactory, these approaches still provide a more comprehensive view of the
inter-relationships among loci. One strong limitation of the study of multi-
locus interactions is population size, because a reduced sample size for each
genotypic class prevents a fair estimation of epistatic effects [114]. It is also
worth noting that in certain experiments where the existence of epistasis has
been addressed, the genetic heterogeneity of the mapping cross has previously
been reduced to increase the power of detection. In the case of the above-
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mentioned experiments seeking cancer susceptibility genes [44,119], genetic
heterogeneity was reduced by creating RCS, in each of which just a fraction of
the genome showed allele segregation [31].
Routman and Cheverud [15] developed a model for the study of two-locus
interactions using information from molecular markers. This model was util-
ized to identify interactions among previously mapped growth QTLs [106].
Forty-three out of 171 pairs of loci showed significant epistatic effects, demon-
strating that interactions among loci are a widespread phenomenon in the
genetic regulation of growth. Interestingly, the authors suggested that loci
exhibiting a larger number of significant interactions could be associated with
candidate genes connected to key metabolic pathways regulating growth.
Validation of interactions among loci is a problematic issue in the study of
epistasis. One way to achieve this would be by replicating the experiments [73].
Another alternative was used by Rapp et al. [104] who confirmed a two-locus
interaction affecting blood pressure in rats by developing single and double
congenic strains.
A different approach to exploring the existence of interactions among loci is
the search for modifier loci that modulate the phenotypic expression of major
single-gene mutations. The existence of such modifiers is usually revealed
by the influence that the genetic background exerts on the expression of a
mutant phenotype; one example is the degree of severity of a disease of genetic
origin [118].
The early experiments of Castle, described by Falconer [40], demonstrated
for the first time the influence of genetic modifiers on the phenotype, attributed
to a major gene. In 1907, Castle started a divergent selection experiment on
Piebald rats to modify the degree of pigmentation. Selection was successful,
and backcrosses of the selected lines to unselected stocks proved that changes
in the frequency of other genes, as opposed to mutations in the Piebald gene,
were responsible for the change in the degree of pigmentation. The existence
of genetic modifiers of major mutations was also demonstrated in selection
experiments with Drosophila melanogaster. Sturtevant successfully modified
the number of bristles in lines carrying the Dichate mutation that normally has
an effect of reducing bristle number [40]. Modifier loci have been identified for
the most diverse traits in humans [99], animals [4,17] and plants [10], proving
that the existence of interactions among loci is a widespread phenomenon, even
in the case of major loci.
The experiment reported by Ewart-Toland et al. [39] provides a good
example of the utility of the modifier locus approach for the genetic dissection
of a complex trait. C57BL/6J-ob/ob mice are obese and have high glucose
levels. Both sexes are sterile, and fertility is restored only by leptin treatment.
However, 42% of male mice from a C57BL/6J-ob/ob × BALB/cJ F2 cross
were fertile, even without leptin treatment. Four loci capable of restoring the
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fertility of ob/ob males were identified in that cross. Moreover, the actions
of these loci did not modify the obesity and diabetic condition of ob/ob mice,
proving that these two factors were not responsible for their infertility.
Recently, Corva et al. [24] screened 260 hg/hg mice from a C57BL/6J-
hg/hg × CAST/EiJ F2 cross, in order to identify genetic modifiers of hg.
Nine significant loci associated with different traits were identified. Loci
on chromosomes 1, 2 and 8 affected the weight gain of F2 mice. Loci on
chromosomes 2 and 11 affected weight gain and carcass lean mass (protein and
ash). A locus on chromosome 9 modified femur length and another locus on
chromosome 17 affected both carcass lean mass and femur length, but neither
had significant effects on weight gain. Loci on chromosomes 5 and 9 modified
carcass fat content. The typing of selected markers in+/+mice from the same
F2 cross revealed significant interactions between hg and four growth QTLs
associated with weight gain and body composition on chromosomes 2, 9, 11
and 17. These interactions were detected as changes in gene action (additive
or dominant) and in allele substitution effects.
2.5. Identification of gene/s underlying a QTL
The ultimate goal of a QTL mapping project is the cloning of the genes
responsible for a complex phenotype. In order to achieve that goal, it is usually
necessary to complete three consecutive stages: detection of QTLs in a genome
scan, estimation of QTL location, and fine mapping [28]. It has been suggested
that a degree of resolution of at least 1-cM should be achieved in fine mapping
before proceeding to the stage of physical mapping and gene identification [28].
One way to refine the position of a QTL is to do a “genetic chromosome
dissection” (GCD) of an interval of interest [27]. The GCD can be performed
in mouse crosses using interval-specific congenic strains (ISCS) [27]. This
strategy is based on the creation of a series of congenic strains spanning the
interval to which a QTL has been mapped. The congenics have a uniform
genetic background, and each one carries a different 1-cM segment from a
donor line. Phenotypic analysis of the congenics would establish which strains
carry the gene to be cloned. The creation of the congenics can be optimized in
order to minimize the number of mice needed, as well as the work entailed by
phenotyping and genotyping.
The increasing availability of transcript maps for humans and mice have
made it possible to develop a variant of the positional cloning method, known
as cloning by a positional candidate approach [21]. This method implies
searching for genes that could be assigned to a previously mapped QTL due
to their location and function. Knowledge about genes in a region of interest
simplifies the work of gene identification by chromosome walking, sequencing
and contig assembly. The recently redefined objectives of the Human Genome
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Project Consortium contemplate sequencing the entire mouse genome [22]. In
fact, the sequencing of BACs harboring loci of special biomedical importance is
in progress [95]. This project will soon make the sequences of all mouse genes
in public databases available, together with positional information. Therefore,
gene identification in the near future will take advantage of comparative gen-
ome mapping in the so-called sequence-based era [117]. One example of a
strategy that would benefit from this new knowledge to confirm the identity of
a QTL would be the creation of transgenic mice through whole BAC or BAC
modifications for complementation and rescue of a given phenotype [1,102].
3. CONCLUDING REMARKS
The results pertaining to QTL mapping experiments for growth suggest that
genetic factors regulating growth can be individualized. Growth QTLs have
been mapped to all the mouse chromosomes. Some chromosomes, such as 1,
4, 6 and 11 seem to be consistently reported as harboring growth QTLs, while
others (chromosomes 3, 10, 16, 19) are seldom mentioned. However, this does
not take into account differences in chromosome length and choice of lines
used in the mapping crosses. There does not seem to be a specific pattern
of QTL distribution, and in most cases the map position does not coincide
with the location of genes known to affect growth, such as genes controlling
hormones and growth factors. The number of QTLs reported in genome-wide
scans is extremely variable; therefore it is difficult with the present information
to define the number of loci affecting growth. Moreover, there are striking
differences in the magnitude of the effects of individual QTLs. Population
size seems to be a very important factor limiting the detection power of the
different experiments. There are also differences among laboratories in the
criteria defining significance thresholds, which contributes to the discrepancy
in the number of QTLs affecting a given trait.
With regard to the type of gene action of growth QTLs, no generalizations
can be made. There is evidence of additive effects as well as dominance and
even overdominance [120] effects on the genetic control of growth traits. For
instance, Cheverud et al. [16] reported the existence of underdominance in his
experiment.
Even for those experiments in which the highest number of growth QTLs
have been detected, only a fraction of the genetic variability has been explained,
implying that not all of the genetic factors underlying the trait have been identi-
fied. QTL effects are usually expressed as a fraction of the phenotypic variance,
making it difficult to estimate the contribution of a QTL to the heritability of a
trait. For example, in the experiment of Cheverud et al. [16] mapped QTLs for
10-wk weight explained 76.1% of the phenotypic variance, with contributions
of single QTL between 1.8% and 15.2%, whereas Brockmann et al. [7] reported
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a single QTL on chromosome 11 accounting for up to 35% of the phenotypic
variance of 6-wk body weight. When estimates of the contribution of QTLs
to the heritability of a trait have been made, much lower values are obtained.
The QTLs identified by Morris et al. [91] accounted for heritabilities of 14%,
5% and 12% for 3, 6 and 10-wk weight, respectively; in the experiment of
Keightley et al. [64] the heritability associated with individual markers had
values between 0.3% and 0.7%.
In most cases, the alleles that increase the value of a trait at a particular locus
in the mapping cross come from the parental line with a higher phenotypic
mean; however, there are exceptions to this rule [16]. In fact, it has been
possible to identify growth QTLs in crosses from lines that did not show
substantial differences in size [91]. These results emphasize the importance of
the genetic background on the effects of a particular QTL.
Independently of the method of choice to search for a QTL, the most challen-
ging task will be the confirmation that a given gene is in reality responsible for
the QTL effect. Innovative genetic tools for testing candidate genes are being
developed, and they combine the use of transgenics and gene knockouts, the
creation of congenic lines [105] and the use of large mutant mouse resources
produced by N-ethyl-N ′-nitrosourea (ENU) treatment [59,60].
QTL mapping for growth has been a prolific field over the last years. How-
ever, a few alternatives can be suggested to accelerate the pace of the process
towards the identification of the genes underlying growth QTLs. For example,
one of the factors contributing to the lack of correspondence among QTLs, that
prevents the confirmation of QTL locations, is the complexity of the phenotypes
that are measured when studying the genetics of growth. In fact, complex traits
such as growth rate can be considered “life history traits” [66]. The analysis of
intermediate phenotypes connected with growth, such as muscle and skeleton
size, or even cell number and size in selected tissues, would probably eliminate
the so-called “phenotype gap” that exists in the genetic analysis of complex
traits [51]. Measurement of specific intermediate phenotypes would also avoid
the confounding effects of body composition when studying the genetics of
linear growth.
There is also a paucity of experiments investigating interactions among
loci (epistasis) in growth regulation. Results reported by Routman and
Cheverud [106] on the existence of numerous two-loci interactions affecting
body size in the same mapping population used by Cheverud et al. [16],
demonstrated that epistasis makes an important contribution to the variability
of growth traits in a population.
With regard to the mapping populations used in most experiments, the
convenience of using crosses among common inbred lines has undermined
the value of wild-derived mouse strains as a source of genetic variability.
Therefore, the analysis of some aspects of the genetic architecture of growth
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such as the study of epistasis mentioned above, would require “specialized”
populations, such as Recombinant Congenic or Recombinant Inbred strains, in
which as many as possible the common lines are represented.
Presently there is no uniform nomenclature in the literature to refer to
QTLs, possibly because QTLs are considered to have transitory chromosomal
positions until the corresponding gene is identified. However, this lack of
nomenclature makes it very difficult to search the literature, to identify QTL
location and understand the information underlying the names that they have
been given. In order to bring some uniformity to these data and to include
searchable information on the QTL names, a consensus nomenclature system
needs to be developed by the mouse QTL mapping community.
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